NGM Biopharmaceuticals, Inc. is a private biotech company dedicated to discovering and developing the next generation of medicines for the treatment of serious diseases. Our experienced scientific team has joined forces with an impressive group of industry professionals, Nobel Laureates and other distinguished researchers to form a company where innovation and cutting edge science has provided the foundation for a robust drug discovery engine. To date, NGM Bio has generated a pipeline of six drug candidates in various stages of development, including NGM282 that recently demonstrated proof-of-concept in a Phase 2 study in non-alcoholic steatohepatitis (NASH). In 2015, we entered into a broad, strategic collaboration with Merck that will provide us with the resources and flexibility to pursue our ambitious R&D goals and further extend our pipeline of novel drug candidates.
We are looking for a highly motivated Scientist to join our Translation Science team. This individual would design, develop, execute and analyze tissue-based assays to support target expression and characterization for drug discovery and development in a highly collaborative biotech environment.
Ph.D. or Master’s degree with 5 years of molecular pathology experience
Skilled in tissue-based assays, such as IHC, multiplex IHC/IF, in situ hybridization (ISH),immunofluorescence imaging, specialized tissue sectioning and histology procedures
An expert in design, interpretation, analysis and presentation of data, and understand the biological context of tissue-based studies
Able to manage multiple projects simultaneously
May supervise other members of the team
Experience with image analysis is preferred
Experience with basic tissue morphology is preferred